Healthcare Health/Fitness

Amgen Scraps Experimental Weight Loss Pill, Moves Forward With Injectable Drug in Development for Obesity

Amgen will discontinue its experimental weight loss pill and focus on developing injectable drugs and other obesity-related products.


USDA Recalls 16,000 Pounds of Walmart Ground Beef Over E. coli Contamination

The USDA announced a nationwide recall of over 16,000 pounds of ground beef sold at Walmart due to potential E. coli contamination. The beef originated from Cargill Meat Solutions in Hazleton, Pennsyl..

Peloton CEO Barry McCarthy to Step Down While the Company Faces a Series of Layoffs Due to Low Profits

Peloton undergoes leadership change with CEO Barry McCarthy stepping down, accompanied by layoffs of 15% of staff, following disappointing fiscal third-quarter results...

Novo Nordisk's Q1 Profit Surges 28%, Thanks To Booming Demand for Weight Loss Drugs

Novo Nordisk exceeded profit expectations in Q1 2024 with a 28% surge in net profit, driven by Wegovy's success...


Latest News

Australia's CSL buys Novartis influenza vaccine unit for $275 million
Australia's CSL Ltd (CSL.AX), the world's largest blood products company, said on Monday it had agreed to buy Novartis AG's (NOVN.VX) global influenza vaccine business for $275 million.
Salesforce to make big push into healthcare industry
Salesforce Inc is betting big on healthcare, hiring key personnel and ramping up investment in hopes of replacing outmoded medical industry infrastructure and carving out a $1 billion annual business.
Actavis, Sanofi among bidders for Omega Pharma
Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV [COUCKO.UL], Bloomberg reported, citing people familiar with the matter.
Investors eye third quarter medical use from hospitals, insurers
Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, accord
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Medical Affai
Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology
Vernalis plc today announces that it has licensed worldwide rights in vipadenant (V2006), a small molecule A2A receptor antagonist, to RedoxTherapies Inc (Redox). Vipadenant has the potential to disru
Herbalife hires former U.S. regulator to head compliance team
Herbalife Ltd, the marketer of weight-management products, energy drinks and nutrition supplements that has come under investigation by the Federal Trade Commission as well as other agencies, has hire
Global spa, wellness industry estimated at $3.4 trillion: report
A growing middle class and consumers' evolving attitudes toward health and travel have fueled a global spa and wellness industry worth an estimated $3.4 trillion in 2013, according to a report release
UnitedHealth to buy doctor management company MedSynergies
UnitedHealth Group Inc (UNH.N) said on Tuesday it agreed to buy MedSynergies, which manages physician practices, adding about 9,300 doctors to the hospital and health system services that its Optum te
France uses tax to put pressure on hepatitis C drug prices
France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences
Real Time Analytics